Marc Cobo serves as Senior Vice President - Finance, Chief Accounting Officer of the Company. He has more than 18 years of experience in corporate accounting, including mergers and acquisitions, compliance, public offering, and financial analysis activities. Prior to joining the Company, Mr. Cobo served as Vice President of Finance at Sangamo Therapeutics, Inc. ("Sangamo"), a biotechnology company, with responsibility for accounting, procurement, IT and facilities from January 2018 to May 2019, and held various roles of increasing responsibilities within Sangamo since March 2014 (serving as Controller from October 2015 to December 2017 and Assistant Controller from March 2014 to September 2015). Prior to joining Sangamo, Mr. Cobo was a Senior Manager, Accounting, at Responsys, Inc., a software company, from June 2012 until March 2014 when the company was acquired by Oracle Corporation ("Oracle"). Prior to that position, Mr. Cobo held various roles of increasing responsibilities at Oracle, in the mergers and acquisition, technical accounting and SEC reporting teams, from November 2006 to June 2012. He started his career in audit at Ernst and Young LLP from 2002 to 2006 in the firm's biotechnology and technology practices. Mr. Cobo holds a B.S. in accounting from Santa Clara University, and is a licensed Certified Public Accountant.
Marc Cobo is 40, he's been the Senior Vice President - Finance e Chief Accounting Officer of Tricida Inc since 2020. There are 15 older and 1 younger executives at Tricida Inc. The oldest executive at Tricida Inc is Robert Alpern, 69, who is the Independent Director.
Marc's mailing address filed with the SEC is 7000 SHORELINE COURT, SUITE 201, , SOUTH SAN FRANCISCO, CA, 94080.
Over the last 6 years, insiders at Tricida Inc have traded over $198,373,537 worth of Tricida Inc stock and bought 7,174,449 units worth $105,536,837 . The most active insiders traders include David P Bonita, Advisors Llc Orbi Med Capit..., eHealthcare Capital Partners.... On average, Tricida Inc executives and independent directors trade stock every 8 days with the average trade being worth of $22,553. The most recent stock trade was executed by Robert J Alpern on 23 November 2022, trading 131,879 units of TCDA stock currently worth $27,695.
Tricida Inc executives and other stock owners filed with the SEC include: